ScholarIQanswers from OpenAlex & ORCID
Olivier Casasnovas
ResearcherPublications, citations & collaboration network
Olivier Casasnovas is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Olivier Casasnovas have?
ScholarIQindexed works
Olivier Casasnovas has 627 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Olivier Casasnovas have?
ScholarIQcitation count
Olivier Casasnovas has 25,164 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Olivier Casasnovas?
ScholarIQh-index
Olivier Casasnovas has an h-index of 86 in OpenAlex.
What is the i10-index of Olivier Casasnovas?
ScholarIQi10-index
Olivier Casasnovas has an i10-index of 256 in OpenAlex.
What is the ORCID of Olivier Casasnovas?
ScholarIQorcid
The ORCID for Olivier Casasnovas is on the source record.
What is the OpenAlex record for Olivier Casasnovas?
ScholarIQopenalex
The OpenAlex for Olivier Casasnovas is on the source record.
What are the most-cited papers on Olivier Casasnovas?
ScholarIQmost cited works
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
Franck Morschhauser, Nathan Fowler, Pierre Feugier, Réda Bouabdallah, Hervé Tilly, M. Lia Palomba, Christophe Fruchart, Edward N. Libby, Olivier Casasnovas, Ian W. Flinn, Corinne Haïoun, Hervé Maisonneuve, Loïc Ysebaert, Nancy L. Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Nicolas Daguindau, Steven Le Gouill, Gian M. Pica, Alejandro Martı́n, Armando López‐Guillermo, Jean-François Larouche, Kiyoshi Ando, María Gomes da Silva, Marc André, Pierre Zachée, Laurie H. Sehn, Kensei Tobinai, Guillaume Cartron, David Liu, Jianming Wang, Luc Xerri, Gilles Salles
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Maria Corinna Palanca-Wessels, Myron S. Czuczman, Gilles Salles, Sarit Assouline, Laurie H. Sehn, Ian W. Flinn, Manish R. Patel, Randeep Sangha, Anton Hagenbeek, Ranjana H. Advani, Hervé Tilly, Olivier Casasnovas, Oliver W. Press, Sreeni Yalamanchili, Robert S. Kahn, Randall Dere, Dan Lü, Surai Jones, Cheryl Jones, Yu-Waye Chu, Franck Morschhauser
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network
Sophie Langner-Lemercier, Caroline Houillier, Carole Soussain, Hervé Ghesquières, Olivier Chinot, Luc Taillandier, Pierre Soubeyran, T. Lamy, Franck Morschhauser, Alexandra Benouaich‐Amiel, Guido Ahle, Marie‐Pierre Moles‐Moreau, Cécile Moluçon‐Chabrot, Pascal Bourquard, Ghandi Damaj, Fabrice Jardin, Delphine Larrieu, Emmanuel Gyan, Rémy Gressin, Arnaud Jaccard, Sylvain Choquet, Annie Brion, Olivier Casasnovas, Philippe Colin, Oumédaly Reman, Adrian Tempescul, Jean‐Pierre Marolleau, Michel Fabbro, Florian Naudet, Khê Hoang‐Xuan, Roch Houot